Chemomab announces special shareholder meeting to vote on Scipher merger
CMMB•Chemomab Therapeutics will hold a special shareholder meeting on December 4, 2026, to vote on its proposed merger with Scipher Medicine. Before the proposed private placement, Chemomab equity holders would own about 32% of the combined company and Scipher holders about 68%; the transaction is expected to close in early 2027, subject to approvals and other conditions.
1. Shareholder vote scheduled
Chemomab Therapeutics will hold a special shareholder meeting on December 4, 2026, to vote on its proposed merger with Scipher Medicine. The transaction is expected to close in early 2027, subject to shareholder approval and other closing conditions.
2. Proposed ownership split
Before the proposed private placement, existing Chemomab equity holders would own approximately 32% of the combined company, while Scipher holders would own approximately 68%.
